Jeanne Languepin

Statistics

Publications

Citations

706

H-Index

Active since

2005

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Inserm

Hospices Civils de Lyon

Université Paris Cité

Hôpital Robert-Debré

Jeanne Languepin is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, cystic fibrosis, and cystic fibrosis pharmacotherapy.

ORCID

Publications per year

2005–2025

Publications

Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children

Naïm Ouldali, Julie Toubiana, Denise Antona et al. · JAMA · 2021 · 366 citations · Full text

Medicine, Infectious Diseases, Pediatrics +9

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription

Elise Dréano, Pierre‐Régis Burgel, Aurélie Hatton et al. · European Respiratory Journal · 2023 · 87 citations

Medicine, Pharmacology, Pharmacotherapy +14

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

Naïm Ouldali, Haleh Bagheri, Francesco Salvo et al. · The Lancet Regional Health - Europe · 2022 · 69 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Pierre‐Régis Burgel, Isabelle Sermet‐Gaudelus, Emmanuelle Girodon et al. · The Lancet Respiratory Medicine · 2024 · 47 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Emergence and Within-Host Genetic Evolution of Methicillin-Resistant <i>Staphylococcus aureus</i> Resistant to Linezolid in a Cystic Fibrosis Patient

Caroline Rouard, Fabien Garnier, Jeremy Leraut et al. · Antimicrobial Agents and Chemotherapy · 2018 · 38 citations · Full text

Life Sciences, Microbiology, Molecular Genetics +17

1–5 of 12